// // Partner Brent Babcock was quoted in, "Pharma, Biotech Patent Holders Lament Appeal Board Survival," an article published by Bloomberg Law. | Knobbe Martens Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock was quoted in, “Pharma, Biotech Patent Holders Lament Appeal Board Survival,” an article published by Bloomberg Law.

June 27, 2018  | Brenton R. Babcock

Partner Brent Babcock was quoted in, “Pharma, Biotech Patent Holders Lament Appeal Board Survival,” an article published by Bloomberg Law.

Excerpt: “Pharmaceutical and life sciences patent holders may be unhappy the Supreme Court this week didn’t spike a review board known for invalidating patents at a high rate, but must be relieved the board can no longer do so piecemeal.”

Read full article here >> (Subscription Required)

 

Related Links

Practice Areas

Industries

News & Insights

Blog - Litigation
Apr 2025
Hard to Stomach: Things You Say to Prosecute a Patent Can and Will Be Used Against You
AZURITY PHARMACEUTICALS, INC. v. ALKEM LABORATORIES LTD. Before Murphy, Moore, and Chen.  Appeal from the United States District Court for the District of Delaware. Summary: Arguments and amendments made during...
News
Mar 2025
Knobbe Martens, Partners Named Among Finalists for Inaugural Life Sciences Patent Network Awards
IRVINE, Calif., March 4, 2025 – Knobbe Martens is proud to announce that the firm and two partners have been named finalists in multiple categories at the inaugural Life Sciences...
News
Apr 2025
Brian Horne Named Among LA’s Top 100 Lawyers by Los Angeles Business Journal
LOS ANGELES, April 28, 2025 – Knobbe Martens is pleased to share that litigation partner Brian Horne has been recognized on Los Angeles Business Journal’s 2025 “Top 100 Lawyers” list....